Who owns MIRUM PHARMACEUTICALS INC NOTE 4.000 5/0?
- CUSIP Number: 604749ab7
Tip: Access positions for across all investors
Analyze quarterly positions in Mirum Pharmaceuticals Inc Note 4.000 5/0 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Mirum Pharmaceuticals Inc Note 4.000 5/0 stock
Who bought or sold MIRUM PHARMACEUTICALS INC NOTE 4.000 5/0 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Deerfield Management Company | 70M | $168M | 0% | Sep 2025 |
|
| Readystate Asset Management | 30M | $73M | -10% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 29M | $75M | 198% | Dec 2025 |
|
| MacKay Shields | 26M | $66M | -3% | Dec 2025 |
|
| Tenor Capital Management | 25M | $61M | 100% | Sep 2025 |
|
| Citadel Advisors | 24M | $59M | 9% | Sep 2025 |
|
| Polar Securities | 21M | $52M | 100% | Sep 2025 |
|
| Capstone Investment Advisors | 19M | $46M | 100% | Sep 2025 |
|
| Lazard Asset Management | 12M | $296k | 492% | Dec 2025 |
|
| Point72 Asset Management | 9.4M | $23M | 0% | Sep 2025 |
|
| FMR | 6.1M | $15M | -7% | Sep 2025 |
|
| Aristeia Capital | 6.0M | $14M | 0% | Sep 2025 |
|
| Aequim Alternative Investments | 6.0M | $14M | 0% | Sep 2025 |
|
| SSI Investment Management | 4.1M | $11M | -27% | Dec 2025 |
|
| Lord, Abbett & Co | 4.0M | $9.6M | -13% | Sep 2025 |
|
| BlackRock | 3.0M | $7.3M | -2% | Sep 2025 |
|
| Invesco | 2.5M | $6.0M | 0% | Sep 2025 |
|
| Nicholas Investments Partners | 2.3M | $5.8M | -25% | Dec 2025 |
|
| Linden Advisors | 2.0M | $4.8M | 100% | Sep 2025 |
|
| Franklin Resources | 1.9M | $4.8M | -92% | Dec 2025 |
|
| Ameriprise Financial | 1.5M | $3.6M | -84% | Sep 2025 |
|
| Advent Capital Management | 1.4M | $3.6M | 28% | Dec 2025 |
|
| Kornitzer Capital Management | 1.1M | $2.8M | 0% | Dec 2025 |
|
| Kohlberg Kravis Roberts & Co | 894k | $2.2M | 0% | Sep 2025 |
|
| Agf Management | 700k | $1.7M | 0% | Sep 2025 |
|
| Wells Fargo & Company | 524k | $1.4M | -2% | Dec 2025 |
|
| Barclays | 373k | $968k | 4% | Dec 2025 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 363k | $939k | 53% | Dec 2025 |
|
| Sei Investments | 228k | $588k | 0% | Dec 2025 |
|
| Central Pacific Bank - Trust Division | 125k | $323k | 0% | Dec 2025 |
|
| Nomura Holdings | 96k | $7.1M | 100% | Sep 2025 |
|
| Oppenheimer Asset Management | 64k | $165k | 0% | Dec 2025 |
|
| Calamos Advisors | 41k | $106k | 32% | Dec 2025 |
|
| Stephens | 20k | $52k | 0% | Dec 2025 |
|
| Balboa Wealth Partners | 10k | $26k | 0% | Dec 2025 |
|
| Goss Wealth Management | 10k | $26k | 100% | Dec 2025 |
|
| Stonegate Investment Group | 10k | $24k | -17% | Sep 2025 |
|
| CoreCap Advisors | 2.0k | $5.1k | 100% | Dec 2025 |
|
| Steward Partners Investment Advisory | 1.0k | $2.4k | 0% | Sep 2025 |
|
| UBS Group | 670.00 | $1.7k | 0% | Dec 2025 |
|
Who sold out of Mirum Pharmaceuticals Inc Note 4.000 5/0?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Royal Bank of Canada | Jun 2025 | 1.1M | $2.0M |
| 683 Capital Management | Jun 2025 | 1.0M | $1.8M |
| Bank of New York Mellon | Sep 2025 | 100k | $237k |
| Context Capital Management | Jun 2025 | 18k | $32M |
| Fifth Third Bancorp | Sep 2025 | 4.0k | $961k |
| Raymond James Financial | Jun 2025 | 1.0k | $1.8k |